ketanserin has been researched along with Lymphoproliferative Disorders in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Lymphoproliferative Disorders: Disorders characterized by proliferation of lymphoid tissue, general or unspecified.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Velnati, S | 1 |
| Ruffo, E | 1 |
| Massarotti, A | 1 |
| Talmon, M | 1 |
| Varma, KSS | 1 |
| Gesu, A | 1 |
| Fresu, LG | 1 |
| Snow, AL | 1 |
| Bertoni, A | 1 |
| Capello, D | 1 |
| Tron, GC | 1 |
| Graziani, A | 1 |
| Baldanzi, G | 1 |
1 other study available for ketanserin and Lymphoproliferative Disorders
| Article | Year |
|---|---|
Identification of a novel DGKα inhibitor for XLP-1 therapy by virtual screening.
Topics: Cell Death; Computer Simulation; Diacylglycerol Kinase; Drug Evaluation, Preclinical; Humans; Lympho | 2019 |